India, Sept. 26 -- Rapper Young Thug is launching Primal, a new creative holding company focused on building businesses with some of the most influential artists, athletes, and creators in culture. R... Read More
India, Sept. 26 -- Multi-platinum and award-winning singer Charlie Puth has canceled his upcoming Australian and New Zealand tour. No reason has yet been revealed for the cancelation, and it is not kn... Read More
India, Sept. 26 -- Oasis have added more dates to their upcoming Live 2027 World Tour, scheduling new shows in Rome, Italy; Munich, Germany; and at Knebworth House in the U.K. According to the announ... Read More
India, Sept. 26 -- IMUNON Inc. (IMNN), a clinical-stage biotechnology company, last week announced a positive recommendation from an Independent Data Monitoring Committee (IDMC) regarding Phase 2 mini... Read More
India, Sept. 26 -- Clearmind Medicine Inc. (CMND), a clinical-stage biopharmaceutical company, announced this week the publications of three U.S. patents covering certain proprietary drug combinations... Read More
India, Sept. 26 -- CBS and MTV have announced a special tribute to Dolly Parton with a performance by Kacey Musgraves during the 2026 MTV Video Music Awards. Hosted by Snoop Dogg, the VMAs will air S... Read More
India, Sept. 26 -- Ion Beam Applications S.A. (IBAB.BR), a provider of equipment for the radiopharmaceutical industry, on Friday announced the coordination of the LIFEDESTINY program to tackle PFAS en... Read More
India, Sept. 26 -- Calidi Biotherapeutics Inc. (CLDI), a biotechnology company, on Friday announced receiving a notice of non-compliance from the New York Stock Exchange (NYSE) American LLC regarding ... Read More
India, Sept. 26 -- CBS and MTV have announced that Raye, Sombr and Teddy Swims will come together for a tribute performance to honor musical genius and icon George Michael during the 2026 MTV Video Mu... Read More
India, Sept. 25 -- Johnson & Johnson (JNJ), a healthcare company with a broad immunology portfolio, announced topline results from the Phase 4 STAR study showing that TREMFYA (guselkumab) improved axi... Read More